Search

everythinglearnresearchcommunity

for

Search:↓

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

Tinea capitis is a common scalp infection causing hair loss, mostly in young children.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Some drugs used to treat inflammation may cause hair loss.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Hair restoration surgery can lead to swelling, infections, scarring, numbness, hiccups, and poor hair growth.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Pregnancy can cause unique skin issues, some of which may risk the mother and baby's health and need careful treatment.